Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M Seed

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Expert Opinion on Therapeutic Patents|September 7, 2016
Medical countermeasures for unwanted CBRN exposures: Part I chemical and biological threats with review of recent countermeasure patentsVijay K Singh, Melissa Garcia, Stephen Y Wise, et al.
Experimental and Molecular Pathology|March 21, 2003
Inhibition of LPS-induced nitric oxide production in RAW cells by radioprotective thiolsK Sree Kumar, Vijay K Singh, William Jackson, et al.
International Immunopharmacology|February 8, 2011
Mobilized progenitor cells as a bridging therapy for radiation casualties: a brief review of tocopherol succinate-based approachesVijay K Singh, Pankaj K Singh, Stephen Y Wise, et al.
Military Medicine|March 5, 2002
Nutritional approaches to radioprotection: vitamin EK Sree Kumar, Venkataraman Srinivasan, Raymond Toles, et al.
Experimental Hematology|October 27, 2009
Preclinical development of a bridging therapy for radiation casualtiesVijay K Singh, Darren S Brown, Tzu-Cheg Kao, et al.
International Journal of Radiation Biology|June 29, 2017
A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with 'standard of care' medicinal and procedures not requiring regulatory approval for useVijay K Singh, Briana K Hanlon, Paola T Santiago, et al.
Radiation Protection Dosimetry|July 5, 2014
Tocols induce G-CSF and mobilise progenitors that mitigate radiation injuryVijay K Singh, Patricia L P Romaine, Victoria L Newman, et al.
Expert Opinion on Therapeutic Patents|September 10, 2016
Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patentsVijay K Singh, Patricia L P Romaine, Victoria L Newman, et al.
Journal of AOAC International|June 27, 2002
Determination of WR-1065 and WR-33278 by liquid chromatography with electrochemical detectionJames A Pendergrass, Venkataraman Srinivasan, K Sree Kumar, et al.
Military Medicine|March 5, 2002
Development of chemopreventive strategies for radiation-induced cancer: targeting radiation-induced genetic alterationsAlexandra C Miller, E John Ainsworth, Lei Lui, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Expert Opinion on Therapeutic Patents|September 7, 2016
Medical countermeasures for unwanted CBRN exposures: Part I chemical and biological threats with review of recent countermeasure patentsVijay K Singh, Melissa Garcia, Stephen Y Wise, et al.
Experimental and Molecular Pathology|March 21, 2003
Inhibition of LPS-induced nitric oxide production in RAW cells by radioprotective thiolsK Sree Kumar, Vijay K Singh, William Jackson, et al.
International Immunopharmacology|February 8, 2011
Mobilized progenitor cells as a bridging therapy for radiation casualties: a brief review of tocopherol succinate-based approachesVijay K Singh, Pankaj K Singh, Stephen Y Wise, et al.
Military Medicine|March 5, 2002
Nutritional approaches to radioprotection: vitamin EK Sree Kumar, Venkataraman Srinivasan, Raymond Toles, et al.
Experimental Hematology|October 27, 2009
Preclinical development of a bridging therapy for radiation casualtiesVijay K Singh, Darren S Brown, Tzu-Cheg Kao, et al.
International Journal of Radiation Biology|June 29, 2017
A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with 'standard of care' medicinal and procedures not requiring regulatory approval for useVijay K Singh, Briana K Hanlon, Paola T Santiago, et al.
Radiation Protection Dosimetry|July 5, 2014
Tocols induce G-CSF and mobilise progenitors that mitigate radiation injuryVijay K Singh, Patricia L P Romaine, Victoria L Newman, et al.
Expert Opinion on Therapeutic Patents|September 10, 2016
Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patentsVijay K Singh, Patricia L P Romaine, Victoria L Newman, et al.
Journal of AOAC International|June 27, 2002
Determination of WR-1065 and WR-33278 by liquid chromatography with electrochemical detectionJames A Pendergrass, Venkataraman Srinivasan, K Sree Kumar, et al.
Military Medicine|March 5, 2002
Development of chemopreventive strategies for radiation-induced cancer: targeting radiation-induced genetic alterationsAlexandra C Miller, E John Ainsworth, Lei Lui, et al.
Pageof 8